The researchers believe this sensor test has potential in speeding up disease-specific analyses of genetic samples. George Vasmatzis, Ph.D., co-leader of Mayo’s Biomarker Discovery Program in the Center for Individualized Medicine, notes in the release that the assay could eliminate the need for bisulfite conversion of DNA, fluorescent labeling, and polymerase chain reaction (PCR). This research was done through the Mayo Illinois Alliance for Technology Based Healthcare, created in 2010 to advance research and clinical treatment options.
Image of the Month
New Generation Nanogold and Nanosilver Polymer Composites and Their Applications
Zone of inhibition for Staphylococcus aureus bacteria (clear area) around a nanosilver-polyurethane bead (removed) that was positioned on the surface of an inoculated agar plate, as shown by the arrows.
School of Chemical and Physical Sciences, Victoria University of Wellington, New Zealand
NSTI Online Community